Development
Recursion Pharmaceuticals, Inc.
RXRX
$5.49
$0.9220.13%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.10% | -4.57% | -14.22% | -13.96% | 20.95% |
| Total Receivables | -2.21% | 3.70% | 48.32% | -25.28% | -76.34% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 117.00% | -9.34% | 30.59% | -1.32% | 11.81% |
| Total Current Assets | 6.73% | -4.76% | -12.42% | -13.63% | 18.31% |
|
|
|||||
| Total Current Assets | 6.73% | -4.76% | -12.42% | -13.63% | 18.31% |
| Net Property, Plant & Equipment | -0.11% | -3.49% | -0.36% | 3.02% | 1.63% |
| Long-term Investments | -1.32% | -12.83% | 7,455.06% | 0.00% | 0.00% |
| Goodwill | -1.32% | -12.83% | 7,455.06% | 0.00% | 0.00% |
| Total Other Intangibles | -7.64% | -7.71% | 3,144.08% | 0.92% | -10.36% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -11.49% | 0.58% | -3.29% | 1.04% | -2.87% |
| Total Assets | 3.63% | -5.38% | 6.27% | -10.54% | 14.68% |
|
|
|||||
| Total Accounts Payable | -7.32% | 104.46% | -50.88% | -7.39% | 17.89% |
| Total Accrued Expenses | 137.63% | -46.54% | 31.28% | -17.32% | 21.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.77% | 2.63% | 15.57% | -15.67% | 7.33% |
| Total Finance Division Other Current Liabilities | -37.64% | -9.41% | 26.56% | -2.67% | 22.00% |
| Total Other Current Liabilities | -37.64% | -9.41% | 26.56% | -2.67% | 22.00% |
| Total Current Liabilities | -1.01% | -17.41% | 23.67% | -8.09% | 20.75% |
|
|
|||||
| Total Current Liabilities | -1.01% | -17.41% | 23.67% | -8.09% | 20.75% |
| Long-Term Debt | -2.22% | -2.51% | -2.04% | 119.96% | -4.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.00% | -3.38% | -1.97% | 5.29% | -3.42% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -1.38% | 44.99% | -35.59% | -18.74% | -25.18% |
| Total Liabilities | -1.35% | -2.47% | 0.28% | -8.49% | -3.59% |
|
|
|||||
| Common Stock & APIC | 9.03% | 4.96% | 10.18% | 0.86% | 16.00% |
| Retained Earnings | -10.63% | -11.90% | -10.88% | -10.21% | -9.88% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.82% | -6.61% | 9.02% | -11.45% | 25.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.82% | -6.61% | 9.02% | -11.45% | 25.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.82% | -6.61% | 9.02% | -11.45% | 25.20% |
|
|
|||||